Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias
Marcos De Lima, Farhad Ravandi, Munir Shahjahan, Borje Andersson, Daniel Couriel, Michele Donato, Issa Khouri, James Gajewski, Koen Van Besien, Richard Champlin, Sergio Giralt, Hagop Kantarjian
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias'. Together they form a unique fingerprint.